The Valley Desk

Clinical trial reportCancer medicinePublished

A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Cancer medicine
Published
Subject terms
Humans; Fever; Protein Kinase Inhibitors; Female; Clinical Trials, Phase II as Topic; Triple Negative Breast Neoplasms; Nivolumab; Immunotherapy; Solid Tumors; Tnbc; Phase Ib; Mivavotinib
PubMed ID
38501219
PubMed Central ID
PMC10949085
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal